381 related articles for article (PubMed ID: 28258415)
1. Survival of Patients with Serous Uterine Carcinoma Undergoing Sentinel Lymph Node Mapping.
Schiavone MB; Scelzo C; Straight C; Zhou Q; Alektiar KM; Makker V; Soslow RA; Iasonos A; Leitao MM; Abu-Rustum NR
Ann Surg Oncol; 2017 Jul; 24(7):1965-1971. PubMed ID: 28258415
[TBL] [Abstract][Full Text] [Related]
2. Survival of Patients with Uterine Carcinosarcoma Undergoing Sentinel Lymph Node Mapping.
Schiavone MB; Zivanovic O; Zhou Q; Leitao MM; Levine DA; Soslow RA; Alektiar KM; Makker V; Iasonos A; Abu-Rustum NR
Ann Surg Oncol; 2016 Jan; 23(1):196-202. PubMed ID: 25994210
[TBL] [Abstract][Full Text] [Related]
3. Sentinel lymph node mapping alone compared to more extensive lymphadenectomy in patients with uterine serous carcinoma.
Basaran D; Bruce S; Aviki EM; Mueller JJ; Broach VA; Cadoo K; Soslow RA; Alektiar KM; Abu-Rustum NR; Leitao MM
Gynecol Oncol; 2020 Jan; 156(1):70-76. PubMed ID: 31739992
[TBL] [Abstract][Full Text] [Related]
4. Multicenter study comparing oncologic outcomes after lymph node assessment via a sentinel lymph node algorithm versus comprehensive pelvic and paraaortic lymphadenectomy in patients with serous and clear cell endometrial carcinoma.
Schlappe BA; Weaver AL; McGree ME; Ducie J; Zahl Eriksson AG; Dowdy SC; Cliby WA; Glaser GE; Abu-Rustum NR; Mariani A; Leitao MM
Gynecol Oncol; 2020 Jan; 156(1):62-69. PubMed ID: 31776037
[TBL] [Abstract][Full Text] [Related]
5. Outcomes for patients with high-risk endometrial cancer undergoing sentinel lymph node assessment versus full lymphadenectomy.
Holtzman S; Stoffels G; Flint M; Carr C; Prasad-Hayes M; Zeligs K; Blank SV
Gynecol Oncol; 2023 Jul; 174():273-277. PubMed ID: 37270906
[TBL] [Abstract][Full Text] [Related]
6. Sentinel lymph node mapping with indocyanine green in cervical cancer patients undergoing open radical hysterectomy: a single-institution series.
Bizzarri N; Luigi PA; Ferrandina G; Zannoni GF; Carbone MV; Fedele C; Teodorico E; Gallotta V; Gueli Alletti S; Chiantera V; Fagotti A; Scambia G; Fanfani F
J Cancer Res Clin Oncol; 2021 Mar; 147(3):649-659. PubMed ID: 33000339
[TBL] [Abstract][Full Text] [Related]
7. Laparoscopic Indocyanine Green Sentinel Lymph Node Mapping in Endometrial Cancer.
Papadia A; Imboden S; Siegenthaler F; Gasparri ML; Mohr S; Lanz S; Mueller MD
Ann Surg Oncol; 2016 Jul; 23(7):2206-11. PubMed ID: 26790667
[TBL] [Abstract][Full Text] [Related]
8. Two-step sentinel lymph node mapping strategy in endometrial cancer staging using fluorescent imaging: A novel sentinel lymph node tracer injection procedure.
Eoh KJ; Lee YJ; Kim HS; Lee JY; Nam EJ; Kim S; Kim YT; Kim SW
Surg Oncol; 2018 Sep; 27(3):514-519. PubMed ID: 30217312
[TBL] [Abstract][Full Text] [Related]
9. The efficacy of sentinel lymph node mapping with indocyanine green in cervical cancer.
Kim JH; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
World J Surg Oncol; 2018 Mar; 16(1):52. PubMed ID: 29523141
[TBL] [Abstract][Full Text] [Related]
10. The Utility of Sentinel Lymph Node Mapping in High-Grade Endometrial Cancer.
Tanner EJ; Ojalvo L; Stone RL; Levinson K; Temkin SM; Murdock T; Vang R; Sinno AK; Fader AN
Int J Gynecol Cancer; 2017 Sep; 27(7):1416-1421. PubMed ID: 30814241
[TBL] [Abstract][Full Text] [Related]
11. Comparison of a sentinel lymph node mapping algorithm and comprehensive lymphadenectomy in the detection of stage IIIC endometrial carcinoma at higher risk for nodal disease.
Ducie JA; Eriksson AGZ; Ali N; McGree ME; Weaver AL; Bogani G; Cliby WA; Dowdy SC; Bakkum-Gamez JN; Soslow RA; Keeney GL; Abu-Rustum NR; Mariani A; Leitao MM
Gynecol Oncol; 2017 Dec; 147(3):541-548. PubMed ID: 28965698
[TBL] [Abstract][Full Text] [Related]
12. Sensitivity and negative predictive value for sentinel lymph node biopsy in women with early-stage cervical cancer.
Salvo G; Ramirez PT; Levenback CF; Munsell MF; Euscher ED; Soliman PT; Frumovitz M
Gynecol Oncol; 2017 Apr; 145(1):96-101. PubMed ID: 28188015
[TBL] [Abstract][Full Text] [Related]
13. Can risk groups accurately predict non-sentinel lymph node metastasis in sentinel lymph node-positive endometrial cancer patients? A Turkish Gynecologic Oncology Group Study (TRSGO-SLN-004).
Altin D; Taskin S; Tokgozoglu N; Vatansever D; Guler AH; Gungor M; Tasci T; Turan H; Kahramanoglu I; Yalcin I; Celik C; Kose F; Ortac F; Arvas M; Ayhan A; Taskiran C
J Surg Oncol; 2021 Feb; 123(2):638-645. PubMed ID: 33259650
[TBL] [Abstract][Full Text] [Related]
14. A prospective multicenter trial on sentinel lymph node biopsy in patients with early-stage cervical cancer (SENTIX).
Cibula D; Dusek J; Jarkovsky J; Dundr P; Querleu D; van der Zee A; Kucukmetin A; Kocian R
Int J Gynecol Cancer; 2019 Jan; 29(1):212-215. PubMed ID: 30640706
[TBL] [Abstract][Full Text] [Related]
15. The impact on survival of two different staging strategies in apparent early stage endometrial cancer comparing sentinel lymph nodes mapping algorithm and selective lymphadenectomy: An Italian retrospective analysis of two reference centers.
Buda A; Di Martino G; Restaino S; De Ponti E; Monterossi G; Giuliani D; Ercoli A; Dell'Orto F; Dinoi G; Grassi T; Scambia G; Fanfani F
Gynecol Oncol; 2017 Dec; 147(3):528-534. PubMed ID: 29032824
[TBL] [Abstract][Full Text] [Related]
16. A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study.
Rossi EC; Kowalski LD; Scalici J; Cantrell L; Schuler K; Hanna RK; Method M; Ade M; Ivanova A; Boggess JF
Lancet Oncol; 2017 Mar; 18(3):384-392. PubMed ID: 28159465
[TBL] [Abstract][Full Text] [Related]
17. The Impact of Sentinel Node-Mapping in Staging High-Risk Endometrial Cancer.
Baiocchi G; Mantoan H; Kumagai LY; Gonçalves BT; Badiglian-Filho L; de Oliveira Menezes AN; Faloppa CC; De Brot L; da Costa AABA
Ann Surg Oncol; 2017 Dec; 24(13):3981-3987. PubMed ID: 29058141
[TBL] [Abstract][Full Text] [Related]
18. Survival associated with the use of one-step nucleic acid amplification (OSNA) to detect sentinel lymph node metastasis in cervical cancer.
Bizzarri N; Fedele C; Teodorico E; Certelli C; Pedone Anchora L; Carbone V; Giannarelli D; Fagotti A; Zannoni GF; Valente M; Querleu D; Ferrandina G; Scambia G; Fanfani F
Eur J Surg Oncol; 2024 Apr; 50(4):108250. PubMed ID: 38461568
[TBL] [Abstract][Full Text] [Related]
19. Sentinel Node Mapping Using Indocyanine Green and Near-infrared Fluorescence Imaging Technology for Uterine Malignancies: Preliminary Experience With the Da Vinci Xi System.
Siesto G; Romano F; Fiamengo B; Vitobello D
J Minim Invasive Gynecol; 2016; 23(4):470-1. PubMed ID: 26767824
[TBL] [Abstract][Full Text] [Related]
20. Pathological factors associated with non-sentinel lymph node metastasis in early stage cervical cancer.
Diniz TP; Faloppa CC; Mantoan H; Gonçalves BT; Kumagai LY; Menezes ANO; Badiglian-Filho L; Guimaraes APG; da Costa AABA; De Brot L; Baiocchi G
J Surg Oncol; 2021 Mar; 123(4):1115-1120. PubMed ID: 33524165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
